FDA Pre-Submission Filed for Cardio inCode-SCORE : vimarsana

FDA Pre-Submission Filed for Cardio inCode-SCORE

Commencement of regulatory pathway for U.S. market approval OXFORD, England - January 11, 2022 - (Newswire.com) GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the filing of its Pre-Submission...

Related Keywords

United States , United Kingdom , Paul Foulger , Drug Administration , Genincode Us Inc , Genincode Plc , Code Plc , Paul Mcmanus , United Kingdom Based , Release Service , Submission Filed ,

© 2025 Vimarsana